A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Non-Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Cancer Hospital, Beijing, China
Hunan Cancer Hospital, Changsha, China
Cancer Hospital Affiliated to Shandong First Medical University (Shandong Cancer Hospital, Shandong cancer prevention and treatment institute), Jinan, China
The First Affiliated Hospital of Xiamen University, Xiamen, China
Henan Cancer Hospital, Zhengzhou, China